Monkeypox: How are lessons learned guiding us in our responses to upcoming emergencies?
The LSHTM-Charité Global Health Lecture Series brings together leading scientists from the UK, Germany and further afield to present cutting-edge research on pressing global health issues and to discuss the implications of their work for policy and practice. The series is supported by the Bill and Melinda Gates Foundation.
Launching the third phase of the LSHTM-Charité Global Health Lecture series, this event will focus on how we are responding to new global health emergencies in light of the current Monkeypox outbreak. Our speakers will share insights from their research, discuss where we are in the global response, and explore how this outbreak is challenging the lessons learned.
Dr Michael Marks, Associate Professor in the Clinical Research Department at LSHTM and Dr Uwe Koppe, Epidemiologist in the HIV/AIDS, sexually transmitted infections (STIs) and Blood-borne Infections Unit at Robert Koch Institute and Dr Adesola Yinka-Ogunleye, Epidemiologist at the Nigeria Centre for Disease Control, will discuss the key findings and main challenges of the current Monkeypox epidemic.
Professor Beate Kampmann will chair the event and will provide reflections on the global health implications.
Speakers
- Dr Michael Marks
-
Michael Marks is a consultant in infectious diseases at the Hospital for Tropical Diseases in London and an associate professor in the clinical research department at LSHTM. He has particular research interests in STIs and is co-leading a series of studies on monkeypox epidemiology in Spain.
- Dr Uwe Koppe
-
Uwe Koppe is an epidemiologist in the HIV/AIDS, sexually transmitted infections and Blood-borne Infections Unit at Robert Koch Institute. He has particular expertise in observational studies and surveillance.
Since 2017 his research has focused on management and analysis of observational HIV studies and the implementation of surveys on HIV Pre-Exposure Prophylaxis in target groups. Between 2016 and 2017 he was involved in developing a surveillance study for the integrated analysis of antimicrobial consumption and resistance and in the analysis of routine medical data on prevalence and risk factors for antimicrobial resistance in Germany. From 2012 to 2015 he was a medical advisor for respiratory drugs as the local medical project lead for launch of nintedanib in idiopathic pulmonary fibrosis and the medical-scientific support of approved respiratory medicines in COPD and asthma.
He received the degree of MSc Epidemiology from LSHTM in 2010.
He holds a Biochemistry Diploma from the University of Tübingen, Germany and the McGill University of Montreal, Canada, and a PhD from the Charité – Universitätsmedizin Berlin.
Uwe and his team have been strongly involved in the monkeypox public health response and research in Germany.
- Dr Adesola Yinka-Ogunleye
-
Adesola Yinka-Ogunleye is an Epidemiologist and Assistant Director at the Nigeria Centre for Disease Control and a doctoral research candidate in Infectious Diseases Epidemiology at the Institute of Global Health, University College London. She has extensive experience in disease surveillance and public health response to Infectious Diseases in Africa. She led the Nigeria response and control of monkeypox resurgence including the development of national surveillance and response guidelines. She also provides technical supports to the WHO in the ongoing multi-country monkeypox outbreak.
Adesola has also contributed to and led the development of other public health guidelines for various diseases including cholera, Lassa fever, meningitis. She coordinated the review of the Nigeria Integrated Disease Surveillance and Response guidelines in 2019/2020. She is passionate about multisectoral commitment and implementation of One Health in disease control.
She is a 2018/2019 Fellow of the African Public Health Leaders Fellowship, Chatham House, United Kingdom. She is well published in peer-reviewed journals.
- Professor Beate Kampmann
-
Beate Kampmann is a professor of Paediatric Infection &Immunity at LSHTM. She directs the Vaccine Centre at LSHTM and divides her working time between London and The Gambia, West Africa, where she leads the vaccine research at the MRC Unit-The Gambia in West Africa.
She trained in Germany, France, the USA, South Africa and the UK and holds an MD from the University of Cologne and a PhD from Imperial College, UK. She is a Fellow of the Academy of Medical Sciences, the Royal College of Paediatrics and child health in the UK and the West African College of Physicians and an MRC Senior Researcher.
Her translational research portfolio focuses on innate and acquired immune responses to infection and vaccination, including in pregnant women and infants and the conduct of clinical trials of novel vaccines and adjuvants. She is the director of IMPRINT - the IMmunising PRegnant women and INfantsnetwork, a UKRI-GCRF-funded multi-disciplinary and global network of scientists, clinicians and public health representatives with a special interest in vaccines for pregnant women and newborns and has published over 250 articles.
Her team developed the LSHTM COVID-19 vaccine tracker which provides a comprehensive overview of the vaccine pipeline, results of clinical trials and global vaccine implementation.
Admission
Contact
